| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0001314> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0007328> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0008562> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0013725> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0015690> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0024907> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0027775> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0032615> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0243042> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C0599748> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34787883_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Exeltis Healthcare, Ismaning, Germany. pedro-antonio.regidor@exeltis.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/De_La_Rosa_X> <https://research.tib.eu/covid-19/entity/Gracia_Banzo_R> <https://research.tib.eu/covid-19/entity/Regidor_P-A> <https://research.tib.eu/covid-19/entity/Rizo_J_M> <https://research.tib.eu/covid-19/entity/Santos_F_G> <https://research.tib.eu/covid-19/entity/Silva_R_S>
?:doi	<https://research.tib.eu/covid-19/entity/2712310.26355/eurrev_202111_27123>
?:doi	2712310.26355/eurrev_202111_27123
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	European review for medical and pharmacological sciences
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34787883>
?:pmid	<https://research.tib.eu/covid-19/entity/34787883>
?:pmid	34787883
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.68
?:rankingScore_hIndex	43
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0039082_PROCESS_OF_C0030705>
?:title	Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34787883>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34787883>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all